Feedback / Questions
atumelnant (CRN04894) - Crinetics
https://www.globenewswire.com/news-release/2025/08/21/3137152/0/en/Crinetics-Receives-FDA-Orphan-Drug-Designation-for-Atumelnant-in-the-Treatment-of-Congenital-Adrenal-Hyperplasia-CAH.html
Aug 21, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next